Protara Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Protara Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2012 to 2023.
  • Protara Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $931K, a 35.7% decline year-over-year.
  • Protara Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $4.67M, a 23% decline year-over-year.
  • Protara Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $6.09M, a 8.91% decline from 2022.
  • Protara Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $6.69M.
  • Protara Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2019 was $943K, a 72.5% decline from 2018.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.09M -$596K -8.91% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 $6.69M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2019 $943K -$2.49M -72.5% Jan 1, 2019 Dec 31, 2019 10-K 2020-03-20
2018 $3.43M +$202K +6.26% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-20
2017 $3.23M -$116K -3.47% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-13
2016 $3.34M +$1.18M +54.5% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-13
2015 $2.16M +$1.71M +371% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
2014 $459K +$304K +196% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 $155K +$45K +40.9% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
2012 $110K Jan 1, 2012 Dec 31, 2012 10-K 2015-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.